Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis, IGA

Explore clinical trials studying Glomerulonephritis, IGA. Study availability and eligibility vary by location and protocol.

190 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis, IGA trial results

Recruiting

Study of BHV-1400 in IgA Nephropathy

NCT07054684

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +19 more
Locations
  • Site-001 Farmington, Connecticut, United States
  • Site-003 Miami Lakes, Florida, United States
  • Site-011 Miami Lakes, Florida, United States
  • Site-013 Orlando, Florida, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT05797610

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Alabama Kidney Research - ERN - PPDS Alabaster, Alabama, United States
  • UAB Nephrology Research Clinic Birmingham, Alabama, United States
  • Sunrise Medical Management LLC Surprise, Arizona, United States
  • Tucson Neuroscience Research - M3 WR Tucson, Arizona, United States
View all 204 locations
View Trial Details
Recruiting

Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study

NCT06350630

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • CHU Gabriel Montpied Clermont-Ferrand, France
  • Hospices Civils de Lyon Lyon, France
  • AP-HM Hôpital de la Conception Marseille, France
  • APHP Hôpital Bichat Paris, France
View Trial Details
Recruiting

A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

NCT04663204

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, England, United Kingdom
  • Northern Care Alliance NHS Foundation Trust - Salford Royal Salford, England, United Kingdom
  • Royal Infirmary of Edinburgh & Western General Hospital Edinburgh, Scotland, United Kingdom
  • University Hospital of wales Cardiff, Wales, United Kingdom
View Trial Details
Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

NCT06994845

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Prim Childrens Hosp Inv Pharm Salt Lake City, Utah, United States
  • Novartis Investigative Site Brisbane, Queensland, Australia
View all 17 locations
View Trial Details
Recruiting

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

NCT07390123

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Huangshan City People's Hospital Huangshan City, Anhui, China
  • The Second Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Zhanjiang Central Hospital Zhanjiang, Guangdong, China
View Trial Details

Related conditions